Cargando…
Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures
Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that has limited treatment options. The current standard of MPM diagnosis requires the testing of multiple immunohistochemical (IHC) markers on formalin-fixed paraffin-embedded tissue to differentiate MPM...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213505/ https://www.ncbi.nlm.nih.gov/pubmed/30301262 http://dx.doi.org/10.3390/ijms19103056 |
_version_ | 1783367787558731776 |
---|---|
author | Sarun, Kadir Harun Lee, Kenneth Williams, Marissa Wright, Casey Maree Clarke, Candice Julie Cheng, Ngan Ching Takahashi, Ken Cheng, Yuen Yee |
author_facet | Sarun, Kadir Harun Lee, Kenneth Williams, Marissa Wright, Casey Maree Clarke, Candice Julie Cheng, Ngan Ching Takahashi, Ken Cheng, Yuen Yee |
author_sort | Sarun, Kadir Harun |
collection | PubMed |
description | Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that has limited treatment options. The current standard of MPM diagnosis requires the testing of multiple immunohistochemical (IHC) markers on formalin-fixed paraffin-embedded tissue to differentiate MPM from other lung malignancies. To date, no single biomarker exists for definitive diagnosis of MPM due to the lack of specificity and sensitivity; therefore, there is ongoing research and development in order to identify alternative biomarkers for this purpose. In this study, we utilized primary MPM cell lines and tested the expression of clinically used biomarker panels, including CK8/18, Calretinin, CK 5/6, CD141, HBME-1, WT-1, D2-40, EMA, CEA, TAG72, BG8, CD15, TTF-1, BAP1, and Ber-Ep4. The genomic alteration of CDNK2A and BAP1 is common in MPM and has potential diagnostic value. Changes in CDKN2A and BAP1 genomic expression were confirmed in MPM samples in the current study using Fluorescence In situ Hybridization (FISH) analysis or copy number variation (CNV) analysis with digital droplet PCR (ddPCR). To determine whether MPM tissue and cell lines were comparable in terms of molecular alterations, IHC marker expression was analyzed in both sample types. The percentage of MPM biomarker levels showed variation between original tissue and matched cells established in culture. Genomic deletions of BAP1 and CDKN2A, however, showed consistent levels between the two. The data from this study suggest that genomic deletion analysis may provide more accurate biomarker options for MPM diagnosis. |
format | Online Article Text |
id | pubmed-6213505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62135052018-11-14 Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures Sarun, Kadir Harun Lee, Kenneth Williams, Marissa Wright, Casey Maree Clarke, Candice Julie Cheng, Ngan Ching Takahashi, Ken Cheng, Yuen Yee Int J Mol Sci Communication Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that has limited treatment options. The current standard of MPM diagnosis requires the testing of multiple immunohistochemical (IHC) markers on formalin-fixed paraffin-embedded tissue to differentiate MPM from other lung malignancies. To date, no single biomarker exists for definitive diagnosis of MPM due to the lack of specificity and sensitivity; therefore, there is ongoing research and development in order to identify alternative biomarkers for this purpose. In this study, we utilized primary MPM cell lines and tested the expression of clinically used biomarker panels, including CK8/18, Calretinin, CK 5/6, CD141, HBME-1, WT-1, D2-40, EMA, CEA, TAG72, BG8, CD15, TTF-1, BAP1, and Ber-Ep4. The genomic alteration of CDNK2A and BAP1 is common in MPM and has potential diagnostic value. Changes in CDKN2A and BAP1 genomic expression were confirmed in MPM samples in the current study using Fluorescence In situ Hybridization (FISH) analysis or copy number variation (CNV) analysis with digital droplet PCR (ddPCR). To determine whether MPM tissue and cell lines were comparable in terms of molecular alterations, IHC marker expression was analyzed in both sample types. The percentage of MPM biomarker levels showed variation between original tissue and matched cells established in culture. Genomic deletions of BAP1 and CDKN2A, however, showed consistent levels between the two. The data from this study suggest that genomic deletion analysis may provide more accurate biomarker options for MPM diagnosis. MDPI 2018-10-07 /pmc/articles/PMC6213505/ /pubmed/30301262 http://dx.doi.org/10.3390/ijms19103056 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Sarun, Kadir Harun Lee, Kenneth Williams, Marissa Wright, Casey Maree Clarke, Candice Julie Cheng, Ngan Ching Takahashi, Ken Cheng, Yuen Yee Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures |
title | Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures |
title_full | Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures |
title_fullStr | Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures |
title_full_unstemmed | Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures |
title_short | Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures |
title_sort | genomic deletion of bap1 and cdkn2a are useful markers for quality control of malignant pleural mesothelioma (mpm) primary cultures |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213505/ https://www.ncbi.nlm.nih.gov/pubmed/30301262 http://dx.doi.org/10.3390/ijms19103056 |
work_keys_str_mv | AT sarunkadirharun genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT leekenneth genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT williamsmarissa genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT wrightcaseymaree genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT clarkecandicejulie genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT chengnganching genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT takahashiken genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures AT chengyuenyee genomicdeletionofbap1andcdkn2aareusefulmarkersforqualitycontrolofmalignantpleuralmesotheliomampmprimarycultures |